To study the mechanisms of protection against endotoxin challenge offered by antisera to smooth and rough gram-negative organisms, we have developed an assay to quantitate endotoxin neutralization based on inhibition of the Limulus amoebocyte lysate test. Dilutions of different bacterial lipopolysaccharides (LPSs) were incubated with hyperimmune rabbit sera against Escherichia coli 0113, E. coli 018, and rough mutants E. coli J5 and Salmonella minnesota Re595 and were then combined with limulus lysate. The gelation reaction induced by LPS in the lysate was monitored spectrophotometrically, and the concentration of LPS resulting in a 50% lysate response was determined and correlated with antibody titers measured by enzyme-linked immunosorbent assay. Antisera to smooth organisms neutralized homologous LPS markedly and heterologous LPSs only minimally relative to neutralization by preimmune serum. Neutralization of homologous LPS occurred immediately without preincubation of serum and LPS. Antisera to rough mutants neutralized more heterologous LPS than did antisera to smooth organisms. However, this heterologous neutralization required preincubation of serum and LPS and did not appear to be correlated with antibody concentrations. We conclude that antisera to LPS rapidly neutralize the biological activity of the homologous LPS, as detected by limulus lysate, and that neutralization is at least in part antibody mediated. Antisera to rough-mutant organisms slowly neutralized the activity of heterologous LPSs, but this effect appeared not to be correlated with concentrations of antibody to the LPS of the rough mutant, as measured by enzyme-linked immunosorbent assay.
Studies over the last 30 years have demonstrated that antibody to the 0 side chain of the lipopolysaccharide (LPS) of smooth gram-negative bacteria confers protection against homologous but not heterologous LPS challenge in experimental animals (1, 9, 15, 25) . More recently, hyperimmune sera from animals vaccinated with rough-mutant gramnegative organisms have been shown to confer protection against heterologous smooth LPS challenge in a variety of models (2) (3) (4) 12) , although the magnitude of protection was less than that offered by specific homologous antibody. Several studies failed to confirm this finding (7, 8, 18, 20) . It has been hypothesized that the cross protection seen with antisera to rough-mutant organisms is due to antibody directed at a common core antigen that is able to neutralize endotoxin (4, 9, 10, 35) . The numerous investigations exploring this protection are difficult to assess and compare because of the variability of the various in vivo biological models used to assess LPS activity. The requirement for animal models in tests of endotoxin potency has also complicated attempts to investigate the specific mechanisms of protection.
We have described an in vitro test to quantify the neutralization of LPS by serum that is based on the ability of serum to inhibit the activity of LPS on Limulus amoebocyte lysate (LAL) (19) . Using this assay, we have found that human plasma varied 100-fold in neutralizing activity and that LPS incubated in plasma selected on the basis of high neutralizing activity elicited significantly less fever when injected into rabbits than did LPS incubated in plasma selected for low neutralizing activity (32) . In another study we found that sera drawn from rabbits made tolerant to smooth LPS neutralize more heterologous LPS than do normal sera (33) . Further investigation has revealed that injection of macrophage supernatants containing interleukin-1 and recombinant interleukin-1 induces increased serum neutralization of LPS (21) . In light of these experiments and the controversies surrounding the protective mechanism(s) of passively transferred antisera to gram-negative organisms, we used the limulus inhibition assay to study the amounts of LPS neutralized by rabbit antisera directed to rough and smooth gram-negative organisms. We then compared the magnitude of the neutralization activity with the concentrations of antibody to LPS, as measured by enzyme-linked immunosorbent assay (ELISA).
ENDOTOXIN NEUTRALIZATION BY ANTISERA TO E. COLI J5 and E. coli J5. Cells were grown in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.), centrifuged for 15 min at 10,000 x g, washed twice with normal saline, boiled for 2 h, lyophilized, and reconstituted in normal saline at 1 mg/ml. Rabbits were bled one or two times via the central ear artery (preimmune serum) and then immunized intravenously three times per week with vaccine doses increasing from 0.1 to 1.6 ml over 3 weeks. The rabbits were bled 7 days after the last injection (postimmune serum). Antisera to E. coli 0113, E. coli 018, and S. minnesota Re595 were made in individual rabbits. Antiserum to E. coli J5 was made from a pool of six rabbits which were injected and bled concurrently. Immunization of J5-immunized rabbits was continued beyond the initial postimmunization bleed to provide later bleeds. Antiserum to lipid A was made by the method of Galanos et al. (6) by using the intravenous injection schedule described above. Antisera were stored in aliquots at -60°C until use.
ELISAs for anti-LPS antibody. Assays for immunoglobulin G (IgG) and IgM class anti-J5-LPS antibody were performed as previously described (23) . Briefly, flexible polyvinyl plates were coated with LPS at a concentration of 1 ,g/ml for 18 h at 4°C, washed, incubated with serum dilutions overnight at 4°C, washed, and developed with alkaline phosphatase-conjugated heavy-chain-specific goat antirabbit antisera (Cooper Diagnostics, Inc., West Chester, Pa.). The IgG assay was standardized by the method of Zollinger and Boslego (36) Limulus assays. Limulus assays were performed by the spectrophotometric method of Novitsky et al. (19) . A single' lot of LAL produced by Associates of Cape Cod was used for all studies. Dilutions of serum and LPS were made in pyrogen-free 0.9% saline (Abbott). For experiments done without preincubation of serum and LPS, 50 RI of a serum dilution was combined with 100 RI of LAL in each ELISA microtiter well. Dilutions of LPS (50 ,u) were then added, the plate was incubated at 37°C for the times indicated below, and the OD380 was measured on an ELISA reader (Biotek, Burlington, Vt., or Dynatech Laboratories, Inc., Alexandria, Va.). Control experiments in which sera and LAL were incubated at 37°C for 3 h before the addition of LPS resulted in identical curves. For experiments with preincubation of sera and LPS, 50 ,I of each were incubated in microtiter wells at 37°C for various times. Reconstituted LAL (100 ,Il) was then added, and the plates were incubated for an additional 60 min at 37°C before the OD380 was read.
For experiments in which the LAL incubation time was 1 h, sera were compared with respect to the LPS concentration required to elicit 50% of the maximal optimal density generated above a base-line value obtained by using pyrogen-free saline alone. This value was called the lysate response 50 (LR50) (see Fig. 2 ). The LR50 of the same serum assayed on separate days varied up to one dilution. Because different LPS lots and different lysate lots behaved slightly differently in the assay, the sera being compared were always examined in the same assay and preimmunization sera were always included for comparison with postimmunization sera. All assays were done at least in duplicate, and the results given are means.
Preparation of 35% ammonium sulfate fractions of postim- 10 ,000 rpm for 20 min, and the supernatant was saved. The precipitate was dissolved in a small volume of pyrogen-free water, and the 35% fractionation was repeated. The precipitate was adjusted to the starting volume of serum by the addition of pyrogen-free phosphate-buffered saline. The two supernatants were combined, washed several times with pyrogen-free phosphatebuffered saline in a pyrogen-free ultrafiltration cell (Model 8050; Amicon Corp., Lexington, Mass.) with a 30,000-molecular-weight-cutoff filter (PM 30) , and adjusted to the starting volume. The procedure using ammonium sulfate at a concentration of 35% was chosen because it has been described as a purification step for rabbit IgM (11, 30) and because most serum neutralizing activity with the LAL test was found in the supernatant with a 35% fractionation but in the precipitate with a 50% fractionation.
RESULTS
Effect of homologous and heterologous antibody on inhibition of LAL. When 1:10 dilutions of preimmune and postimmune antisera to E. coli 0113 were combined with LAL, followed by the addition of LPS dilutions, 10-fold more homologous LPS had to be added to the postimmune serum to elicit similar gelation of the LAL. This reaction over time is shown in Fig. 1 neutralizing activity for heterologous LPS was manifest only with the 3-h preincubation. Fifty-five days after immunization, the neutralizing activity had fallen almost to that of the rologous E. coli 018 LPS, are shown in Fig. 2 . The LR50 preimmune serum, whereas the concentration of IgG antiiomologous LPS was 18-fold higher for postimmune body to E. coli J5 LPS had decreased only minimally, from m than preimmune serum ( Fig. 2A) . On the other hand, 122,000 to 90,000 ng/ml. Serum collected after three booster LR50 to heterologous LPS was similar for postimmune itnmunizations again showed high neutralizing activity for preimmune sera (Fig. 2B) .
heterologous LPSs. ffect of preincubation and dilution on LR50 in preimmune Effect of ammonium sulfate fractionation oh neutralizing postimmune sera. To evaluate the effect of serum diluactivity of antiserum to E. coli J5. The supernatant and on the amount of neutralization seen with homologous precipitate from a 35% amtnonium sulfate fractionation of body, twofold dilutions of pre-and postimmune antisera antiserum to E. coli J5 were examined for ability to neutralcoli 018 were made in normal saline, and the LR50 was ize LPS from E. coli 0113 and P. aeruginosa type 1 and for rmined for each serum dilution. This was done without ibation of serum and LPS (i.e., by combining serum with >104 L and immediately adding LPS dilutions) and with a 3-h 104 oo... ncubation at 37°C of serum and LPS before the LAL was ed. The results are plotted in Fig. 3 (3 weeks, 10 injections) . The rabbits then received two booster injections of 1.6 ml each of vaccine. P4 was from a late bleed 8 weeks after these injections. The rabbits were then boosted again with three more doses over a week, and P5 was drawn 1 week later.
b Determined by ELISA.
c Incubation of LPS with antiserum before addition of limulus lysate.
DISCUSSION
Inhibition by serum of the effect of LPS on limulus lysate has usually been thought of as a difficulty to be overcome to detect circulating LPS for diagnostic purposes. In this study, we used the LAL system to examine the LPS-neutralizing activity of rabbit sera obtained before and after immunization with rough and smooth organisms to elucidate the mechanisms of the protection they provide against endotoxin challenge. A crucial issue is whether the neutralization test that we used in fact measures neutralization of LPS by sera rather than biochemical inhibition of the lysate cascade by elements in the sera. Two lines of evidence suggest that the test measures neutralization of LPS. First, LPS incu- (32) . This makes it unlikely that the limulus inhibition test is measuring merely inhibition of the lysate cascade. The fact that the test predicted neutralization of LPS in a completely unrelated in vivo assay suggests that it has physiological relevance. Second, increasing the incubation period of serum with LPS resulted in increased neutralization even though the sera-lysate incubation time was constant (Tables 1 and 2 ; 19, 31, 32) . This indicates that the sera were acting on the LPS rather than the lysate. Protection of rabbits against the local (2) and generalized (3) Schwartzman phenomena elicited by smooth heterologous LPS has been achieved with passive transfer of antisera to rough-mutant gram-negative organisms. It has been hypothesized that this protection is due to antibody binding to a common core structure deep in the LPS molecule and exerting an antiendotoxin effect. Similarly, numerous studies have demonstrated homologous but not heterologous protection with passive transfer of antisera to the 0 chains of smooth LPS (1, 3, 9, 25) . It has been hypothesized that this protection, which can be achieved with lower doses of antiserum, occurs by formation of antigen-antibody complexes, resulting in rapid clearance of LPS from the bloodstream by the reticuloendothelial system.
Our in vitro results generally parallel those of endotoxin challenge experiments done in rabbits. Postimmune sera raised to smooth organisms neutralized homologous LPS but had little activity against heterologous LPSs. Homologous LPS neutralization was observed immediately, without preincubation of serum and LPS (Table 1) . Presumably, direct binding of LPS by antibody directed against the homologous antigen was at least in part responsible for this rapid neutralization.
The effect of antiserum on the interaction of LPS with limulus lysate has been examined in two studies. Young (34) found that undiluted immune rabbit plasma against the rough mutant S. minnesota Re595 neutralized more homologous LPS than did normal rabbit plasma but did not examine whether it could neutralize heterologous smooth LPS. On the other hand, Webster (33) found that sera with antibody to smooth LPS were unable to neutralize more homologous LPS than normal sera could when examined in a chromogenic assay system. The data of Webster are in conflict with our findings. The use of different serum dilutions, different incubation times, and a chromogenic substrate may account for this discrepancy.
All sera, whether pre-or postimmune, neutralized homologous and heterologous LPSs progressively over time (19) , so that the LR50 measured after a 3-h incubation ("slow" neutralization) was invariably higher than that measured without incubation (Table 1) . Slow neutralization was enhanced after immunization with rough mutants and was directed against all LPSs examined. It was not observed with lipid A antiserum (data not shown), which generally has been found to be nonprotective in experimental models (16) . The LPS of S. minnesota was less potent than other LPSs in producing limulus lysate gelation and was especially susceptible to slow neutralization by both pre-and postimmune sera.
A striking finding was the dramatic effect of dilution on both rapid and slow neutralization. More than 99% of the neutralizing activity disappeared with an eightfold dilution of serum, in agreement with the previous results of Webster (33) . This phenomenon was used to eliminate inhibitors in serum when the LAL assay was used as a diagnostic test to find LPS in sera (5) .
Detoxification of LPS by normal serum was first described in 1957 (14) . Skarnes and Chedid (24) developed an assay to measure this detoxification based on the ability of serum to transform LPS on double-diffusion Ouchterlony plates from a slowly diffusing toxic band into a rapidly diffusing nontoxic band. They hypothesized that the detoxification process involves two steps, disaggregation and then an interaction with lipoprotein (24). Ulevitch et al. (28, 29) confirmed this hypothesis and demonstrated that LPS rapidly binds to high-density lipoprotein and that the LPS-lipoprotein complexes formed are considerably less toxic than native LPS. Munford et al. (17) established that this occurs in vivo and that LPS-containing membrane fragments shed from gramnegative bacteria also bind to high-density lipoproteins and are detoxified. On the other hand, Johnson et al. (13) reported the isolation of a single labile protein from serum capable of detoxifying LPS without interaction with lipoproteins.
Our studies have not directly addressed whether disaggregating components or lipoproteins contribute to or are responsible for the rapid or slow neutralization of LPS in the LAL inhibition assay. Because of the specificity of the response seen, it seems likely that LPS neutralization by antisera to homologous smooth LPS is related to antibody. However, the steep decrease in neutralizing activity with serum dilution may indicate that another plasma component(s), which is present in limiting concentration or labile with dilution, contributes to rapid neutralization by antibody.
Two pieces of evidence support the hypothesis that antibody alone is not responsible for the slow neutralization of heterologous LPSs observed with E. coli J5 antiserum. First, LPS-neutralizing activity and IgG and IgM class antibodies to E. coli J5 LPS segregated differentially after ammonium sulfate fractionation of postimmune serum (Table 3) . We cannot exclude the possibility that antibody played an enabling role in neutralization, since antibody was present in both neutralizing and nonneutralizing fractions. Second, IgG class antibodies to E. coli J5 were maintained at a relatively high titer over time after immunization, whereas neutralizing activity decreased rapidly ( Table 2 ). The transient presence of neutralizing activity after primary or booster immunization is compatible with the hypothesis that an acute-phase reactant is required for neutralization. Supporting this possibility are the reports that the binding of LPS to lipoproteins is altered in acute-phase (27) and tolerant (31) rabbit sera. Tobias et al. (26) have recently described an acute-phase glycoprotein with a molecular weight of 60,000 that binds to LPS extracted from S. minnesota Re595.
We conclude that limulus lysate can be used to provide a quantitative measure of the ability of different antisera to neutralize endotoxin. Antisera to smooth gram-negative organisms displayed increased neutralization of homologous LPS compared with that by preimmune sera, although other serum components may be necessary for this neutralization.
Antisera to rough gram-negative organisms neutralized more heterologous smooth LPS than did preimmunization sera.
However, the degree of neutralization was less than with homologous antiserum and did not correlate with antibody titers to the rough-mutant LPS, as measured by ELISA. Although caution should be exercised in interpreting any single test of LPS activity, the assay may be a useful tool for probing mechanisms of protection against endotoxemia offered by antisera or monoclonal antibodies directed to core elements of LPS. 
